Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E

BACKGROUND: Several lines of evidence suggest that high-density lipoprotein (HDL) reduces Alzheimer’s disease (AD) risk by decreasing vascular beta-amyloid (Aβ) deposition and inflammation, however, the mechanisms by which HDL improve cerebrovascular functions relevant to AD remain poorly understood...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Jerome, Button, Emily B., Martin, Emma M., McAlary, Luke, Gidden, Zoe, Gilmour, Megan, Boyce, Guilaine, Caffrey, Tara M., Agbay, Andrew, Clark, Amanda, Silverman, Judith M., Cashman, Neil R., Wellington, Cheryl L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093966/
https://www.ncbi.nlm.nih.gov/pubmed/32213187
http://dx.doi.org/10.1186/s13024-020-00366-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093966/
https://www.ncbi.nlm.nih.gov/pubmed/32213187
http://dx.doi.org/10.1186/s13024-020-00366-8

Ejemplares similares